Covid-19 roundup: CureVac vaccine now not expected before August — report; A Covid-19 vaccine trial in Africa is ready to test patients with HIV, but there aren't any vaccines available for it
The clock has been ticking for German drugmaker CureVac and its push toward a Covid-19 vaccine. Time might be running out, as a source from the EMA told Reuters that the agency does not expect CureVac to make a decision on the jab’s approval before August.
German health minister Jens Spahn gave an update on the timetable in a Monday call, the story reports.
Previously, the company’s co-founder and chief production officer Florian von der Mülbe blamed delays, at least in part, on supply chain issues caused first by US delays. Vaccine makers looking to house production in Europe are at a disadvantage because suppliers in the US are required to cater to the home market at first under the Defense Production Act, he said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
